
Applied Therapeutics Inc (APLT)
NASDAQ
Year End December 30 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -260.621 | -140.413 | -132.623 | -122.909 | -108.627 | -128.662 | -257.013 |
Return on Equity (%) | 216.208 | 140.288 | -699.393 | -164.058 | -146.159 | -247.772 | 1830.539 |
Return on Invested Capital (%) | -373.746 | -149.279 | -189.035 | -165.518 | -146.613 | -248.852 | 1006.865 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | -1198.469 |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | -1198.469 |
Book Value Per Share | 0.268 | 1.838 | 1.251 | 3.143 | 1.853 | 0.073 | -0.202 |
Earnings Per Share | -0.501 | -1.919 | -1.746 | -3.604 | -3.128 | -1.484 | -1.413 |
Cash Per Share | 0.383 | 2.178 | 0.723 | 2.204 | 1.596 | 0.3 | 0.589 |
Working Capital Per Share | 0.268 | 1.838 | 1.23 | 3.121 | 1.835 | 0.07 | -0.198 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | 0.118 |
EBIT Per Share | -0.501 | -1.919 | -1.746 | -3.604 | -3.128 | -1.484 | -1.413 |
EBITDA Per Share | -0.501 | -1.919 | -1.746 | -3.604 | -3.128 | -1.484 | -1.413 |
Free Cash Flow Per Share | -0.501 | -1.919 | -1.746 | -3.604 | -3.128 | -1.484 | -1.413 |
Year End December 30 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 5.46M | 5.51M | 18.53M | 18.53M | 26.22M | 48.06M | N/A |
Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||
Shares Outstanding | 48.06M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -95.094 | N/A | N/A | N/A | -44177.895 | N/A | N/A |
Net Profit Margin (%) | N/A | -95.094 | N/A | N/A | N/A | -44177.895 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 62.84M |
Price to Earnings Ratio | -0.52 |
Price to Sales Ratio | 6.29 |
Price to Cash Ratio | 1.26 |
Price to Book Ratio | -3.66 |
Dividend Yield | - |
Shares Outstanding | 116.36M |
Average Volume (1 week) | 1.93M |
Average Volume (1 Month) | 2.7M |
52 Week Change | -91.67% |
52 Week High | 10.6237 |
52 Week Low | 0.43305 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.